Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Physiol
2008 Jun 01;58611:2743-52. doi: 10.1113/jphysiol.2008.153346.
Show Gene links
Show Anatomy links
Cyclothiazide: a subunit-specific inhibitor of GABAC receptors.
Xie A
,
Song X
,
Ripps H
,
Qian H
.
???displayArticle.abstract???
We tested the effects of cyclothiazide (CTZ), an agent used to block desensitization of AMPA-type glutamate receptors, on heterologously expressed GABA(C) receptors formed by homomeric rho subunits. CTZ inhibition of GABA(C) receptors was subunit specific; it produced a dose-dependent reduction of the GABA-elicited current on homomeric rho2 receptors with an IC(50) of about 12 microm, but had no significant effect on homomeric rho1 receptors. This differential sensitivity was attributable to a single amino acid located on the second transmembrane domain of the rho subunits. Mutating the residue at this position from serine to proline on the rho2 subunit eliminated CTZ sensitivity, whereas switching proline to serine on the rho1 subunit made the receptor CTZ sensitive. The inhibitory properties of CTZ were consistent with its action as a channel blocker on the receptors formed by rho2 subunits. The effect showed a small degree of voltage dependence, and was due mainly to a non-competitive mechanism that reduced the maximum response elicited by GABA. In addition, the prominent membrane current rebound when co-application of GABA and CTZ was terminated suggests that the binding site for CTZ on the GABA(C) receptor is distinct from that for GABA, and that CTZ acts as a non-competitive antagonist on the GABA(C) receptor. CTZ inhibited the open channel of the GABA(C) receptor with a time constant of about 0.4 s, but the kinetics were approximately 10-fold slower when GABA is absent. The ability of CTZ to interact with various types of neurotransmitter receptors indicates that the drug has multiple actions in the CNS.
Antlitz,
The antihypertensive effect of cyclothiazide, a double blind study.
1967, Pubmed
Antlitz,
The antihypertensive effect of cyclothiazide, a double blind study.
1967,
Pubmed
Bellingham,
A novel presynaptic inhibitory mechanism underlies paired pulse depression at a fast central synapse.
1999,
Pubmed
Bertolino,
Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus.
1993,
Pubmed
Deng,
Cyclothiazide potently inhibits gamma-aminobutyric acid type A receptors in addition to enhancing glutamate responses.
2003,
Pubmed
Diamond,
Asynchronous release of synaptic vesicles determines the time course of the AMPA receptor-mediated EPSC.
1995,
Pubmed
Dingledine,
The glutamate receptor ion channels.
1999,
Pubmed
Dong,
Use-dependent and use-independent blocking actions of picrotoxin and zinc at the GABAC receptor in retinal horizontal cells.
1996,
Pubmed
Enz,
GABAC receptor rho subunits are heterogeneously expressed in the human CNS and form homo- and heterooligomers with distinct physical properties.
1999,
Pubmed
Fletcher,
New developments in the molecular pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and kainate receptors.
1996,
Pubmed
,
Xenbase
Hadley,
Rat alpha6beta2delta GABAA receptors exhibit two distinct and separable agonist affinities.
2007,
Pubmed
,
Xenbase
Ishikawa,
Mechanisms underlying presynaptic facilitatory effect of cyclothiazide at the calyx of Held of juvenile rats.
2001,
Pubmed
Mitchell,
Targeting AMPA receptor gating processes with allosteric modulators and mutations.
2007,
Pubmed
Partin,
Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A.
1993,
Pubmed
,
Xenbase
Partin,
Structural determinants of allosteric regulation in alternatively spliced AMPA receptors.
1995,
Pubmed
,
Xenbase
Partin,
AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate.
1996,
Pubmed
Qian,
The GABAC receptors of retinal neurons.
2001,
Pubmed
Qian,
Molecular and pharmacological properties of GABA-rho subunits from white perch retina.
1998,
Pubmed
,
Xenbase
Qian,
A single amino acid in the second transmembrane domain of GABA rho subunits is a determinant of the response kinetics of GABAC receptors.
1999,
Pubmed
,
Xenbase
Qian,
Picrotoxin accelerates relaxation of GABAC receptors.
2005,
Pubmed
,
Xenbase
Ramsey,
Streptozotocin-induced diabetes modulates GABA receptor activity of rat retinal neurons.
2007,
Pubmed
Rozzo,
Expression and dendritic mRNA localization of GABAC receptor rho1 and rho2 subunits in developing rat brain and spinal cord.
2002,
Pubmed
Sun,
Mechanism of glutamate receptor desensitization.
2002,
Pubmed
Trussell,
Desensitization of AMPA receptors upon multiquantal neurotransmitter release.
1993,
Pubmed
Wang,
A single amino acid in gamma-aminobutyric acid rho 1 receptors affects competitive and noncompetitive components of picrotoxin inhibition.
1995,
Pubmed
,
Xenbase
Wegelius,
Distribution of GABA receptor rho subunit transcripts in the rat brain.
1998,
Pubmed
Yamada,
Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents.
1993,
Pubmed
Zhang,
Structure and function of GABA(C) receptors: a comparison of native versus recombinant receptors.
2001,
Pubmed
Zhang,
Cloning of a gamma-aminobutyric acid type C receptor subunit in rat retina with a methionine residue critical for picrotoxinin channel block.
1995,
Pubmed
,
Xenbase
Zhu,
A single amino acid in the second transmembrane domain of GABA rho receptors regulates channel conductance.
2007,
Pubmed